Search Results - "Tatapudi, Vasishta S"

Results of Two Cases of Pig-to-Human Kidney Xenotransplantation by Montgomery, Robert A., Stern, Jeffrey M., Lonze, Bonnie E., Tatapudi, Vasishta S., Mangiola, Massimo, Wu, Ming, Weldon, Elaina, Lawson, Nikki, Deterville, Cecilia, Dieter, Rebecca A., Sullivan, Brigitte, Boulton, Gabriella, Parent, Brendan, Piper, Greta, Sommer, Philip, Cawthon, Samantha, Duggan, Erin, Ayares, David, Dandro, Amy, Fazio-Kroll, Ana, Kokkinaki, Maria, Burdorf, Lars, Lorber, Marc, Boeke, Jef D., Pass, Harvey, Keating, Brendan, Griesemer, Adam, Ali, Nicole M., Mehta, Sapna A., Stewart, Zoe A.

“…Genetically modified pig kidney xenografts were transplanted into two brain-dead human recipients. The xenografts functioned immediately and showed no evidence…”
Get full text

Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads by Tatapudi, Vasishta S, Montgomery, Robert A

“…The complement system is integral to innate immunity, and it is an essential deterrent against infections. The complement apparatus comprises of >30…”
Get full text

Comparison of artificial intelligence and human-based prediction and stratification of the risk of long-term kidney allograft failure by Divard, Gillian, Raynaud, Marc, Tatapudi, Vasishta S., Abdalla, Basmah, Bailly, Elodie, Assayag, Maureen, Binois, Yannick, Cohen, Raphael, Zhang, Huanxi, Ulloa, Camillo, Linhares, Kamila, Tedesco, Helio S., Legendre, Christophe, Jouven, Xavier, Montgomery, Robert A., Lefaucheur, Carmen, Aubert, Olivier, Loupy, Alexandre

“…Background Clinical decisions are mainly driven by the ability of physicians to apply risk stratification to patients. However, this task is difficult as it…”
Get full text

Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome by Tatapudi, Vasishta S., Lonze, Bonnie E., Wu, Ming, Montgomery, Robert A.

“…Background: Kidney transplantation is the first-line therapy for patients with end-stage renal disease since it offers greater long-term survival and improved…”
Get full text

HLA in transplantation by Montgomery, Robert A., Tatapudi, Vasishta S., Leffell, Mary S., Zachary, Andrea A.

“…The human major histocompatibility complex is a family of genes that encodes HLAs, which have a crucial role in defence against foreign pathogens and immune…”
Get full text

Successful A2 to B Deceased Donor Kidney Transplant after Desensitization for High-Strength Non-HLA Antibody Made Possible by Utilizing a Hepatitis C Positive Donor by Lonze, Bonnie E., Philogene, Mary Carmelle, Friedlander, Rex, Tatapudi, Vasishta S., Lawson, Nikki, Ali, Nicole M., Karpel, H. Charli, Montgomery, Robert A.

“…Desensitization using plasma exchange can remove harmful antibodies prior to transplantation and mitigate risks for hyperacute and severe early acute…”
Get full text

Physiologic considerations of pig-to-human kidney xenotransplantation by Tatapudi, Vasishta S., Griesemer, Adam D.

“…The greatest challenge facing end-stage kidney disease (ESKD) patients is the scarcity of transplantable organs. Advances in genetic engineering that mitigate…”
Get full text

IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody by Lonze, Bonnie E, Tatapudi, Vasishta S, Weldon, Elaina P, Min, Elijah S, Ali, Nicole M, Deterville, Cecilia L, Gelb, Bruce E, Benstein, Judith A, Dagher, Nabil N, Wu, Ming, Montgomery, Robert A

“…OBJECTIVES:The presence of a donor-specific positive crossmatch has been considered to be a contraindication to kidney transplantation because of the risk of…”
Get full text

Pig-to-human heart xenotransplantation in two recently deceased human recipients by Moazami, Nader, Stern, Jeffrey M., Khalil, Karen, Kim, Jacqueline I., Narula, Navneet, Mangiola, Massimo, Weldon, Elaina P., Kagermazova, Larisa, James, Les, Lawson, Nikki, Piper, Greta L., Sommer, Philip M., Reyentovich, Alex, Bamira, Daniel, Saraon, Tajinderpal, Kadosh, Bernard S., DiVita, Michael, Goldberg, Randal I., Hussain, Syed T., Chan, Justin, Ngai, Jennie, Jan, Thomas, Ali, Nicole M., Tatapudi, Vasishta S., Segev, Dorry L., Bisen, Shivani, Jaffe, Ian S., Piegari, Benjamin, Kowalski, Haley, Kokkinaki, Maria, Monahan, Jeffrey, Sorrells, Lori, Burdorf, Lars, Boeke, Jef D., Pass, Harvey, Goparaju, Chandra, Keating, Brendan, Ayares, David, Lorber, Marc, Griesemer, Adam, Mehta, Sapna A., Smith, Deane E., Montgomery, Robert A.

“…Genetically modified xenografts are one of the most promising solutions to the discrepancy between the numbers of available human organs for transplantation…”
Get full text

Differences in national and international guidelines regarding use of kidney stone formers as living kidney donors by Tatapudi, Vasishta S, Goldfarb, David S

“…PURPOSE OF REVIEWTraditionally, nephrolithiasis was considered a relative contraindication to kidney donation because of a risk of recurrent stones in donors…”
Get full text

IgG Degrading Enzyme of Streptococcus Pyogenes: An Exciting New Development in Desensitization Therapy by Montgomery, Robert A., Lonze, Bonnie E., Tatapudi, Vasishta S.

Get full text

Impact of the 2014 kidney allocation system changes on trends in A2/A2B into B kidney transplantation and organ procurement organization reporting of donor subtyping by Stern, Jeffrey, Alnazari, Nasser, Tatapudi, Vasishta S., Ali, Nicole M., Stewart, Zoe A., Montgomery, Robert A., Lonze, Bonnie E.

“…The current kidney allocation system (KAS) preferentially allocates kidneys from blood type A2 or A2B (A/A2B) donors to blood type B candidates. We used…”
Get full text

High Prevalence of CKD of Unknown Etiology in Uddanam, India by Tatapudi, Ravi Raju, Rentala, Satyanarayana, Gullipalli, Prasad, Komarraju, Aruna Lakshmi, Singh, Ajay K., Tatapudi, Vasishta S., Goru, Krishna Babu, Bhimarasetty, Devi Madhavi, Narni, Hanumanth

“…There were concerns raised regarding a high prevalence of chronic kidney disease (CKD) in Uddanam, a fertile subtropical low-altitude territory in the southern…”
Get full text

Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d⁺ Antibody-Mediated Rejection in Kidney Transplant Recipients by Tatapudi, Vasishta S, Kopchaliiska, Dessislava, da Gente, Gilberto J, Buenaventura, Owen F, Singh, Manpreet, Laszik, Zoltan, Adey, Deborah B, Rajalingam, Raja

“…BACKGROUND Solid-phase assays to investigate the complement-activating capacity of HLA antibodies have been utilized to optimize organ allocation and improve…”
Get full text

Immune response, phenotyping and molecular graft surveillance in kidney transplant recipients following severe acute respiratory syndrome coronavirus 2 vaccination by Ali, Nicole M, Herati, Ramin S, Mehta, Sapna A, Leonard, Jeanette, Miles, Jake, Lonze, Bonnie E, DiMaggio, Charles, Tatapudi, Vasishta S, Stewart, Zoe A, Alnazari, Nasser, Neumann, Henry J, Thomas, Jeffrey, Cartiera, Katarzyna, Weldon, Elaina, Michael, Jennifer, Hickson, Christopher, Whiteson, Harris, Khalil, Karen, Stern, Jeffrey M, Allen, Joseph R, Tuen, Michael, Gray‐Gaillard, Sophie L, Solis, Sabrina M, Samanovic, Marie I, Mulligan, Mark J, Montgomery, Robert A

“…Background Understanding immunogenicity and alloimmune risk following severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination in kidney…”
Get full text

Pharmacologic Complement Inhibition in Clinical Transplantation by Tatapudi, Vasishta S., Montgomery, Robert A.

“…Purpose of Review Over the past two decades, significant strides made in our understanding of the etiology of antibody-mediated rejection (AMR) in…”
Get full text

Symptomatic Central Venous Stenosis in a Hemodialysis Patient Leading to Loss of Arteriovenous Access: A Case Report and Literature Review by Tatapudi, Vasishta S., Spinowitz, Noam, Goldfarb, David S.

“…Central venous stenosis is a well-described sequel to the placement of hemodialysis catheters in the central venous system. The presence of an ipsilateral…”
Get full text

414.2: Histological and Molecular Characterization of Kidney Xenografts Transplanted to Decedent Humans by Loupy, Alexandre, Giarraputo, Alessia, Goutaudier, Valentin, Robin, Blaise, Mezine, Fariza, Mangiola, Massimo, Stern, Jeffrey, Griesemer, Adam, Tatapudi, Vasishta S, Ali, Nicole, Mehta, Sapna, Stewart, Zoe, Ayares, David, Bruneval, Patrick, Montgomery, Robert

Get full text

Correction to: Pharmacologic Complement Inhibition in Clinical Transplantation by Tatapudi, Vasishta S., Montgomery, Robert A.

“…The article Pharmacologic Complement Inhibition in Clinical Transplantation, written by Vasishta S. Tatapudi and Robert A. Montgomery, was originally published…”
Get full text

Successful A2 to B Deceased Donor Kidney Transplant after Desensitization for High-Strength Non-HLA Antibody Made Possible by Utilizing a Hepatitis C Positive Donor by Karpel, H Charli, Ali, Nicole M, Lawson, Nikki, Tatapudi, Vasishta S, Friedlander, Rex, Philogene, Mary Carmelle, Montgomery, Robert A, Lonze, Bonnie E

Get full text